SCHEMBL4060187

SCHEMBL4060187

c1ccc2c(c1)c1ccccc1n2OCC1CO1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
ALDH1A1 P00352 2/20 0.42
GLA P06280 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HIF1A Q16665 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
BBOX1 O75936 1/20 0.36
ASPH Q12797 1/20 0.36
KDM8 Q8N371 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7097355 0.77 MEN1 (0.45) DHFRTDP1ALDH1A1CYP1A2TSHR
SCHEMBL9390933 0.75 MEN1 (0.55) DHFRTDP1ALDH1A1CYP1A2CYP2C19
SCHEMBL7328991 0.74 DHFR (0.41) DHFRTDP1ALDH1A1GLATP53
SCHEMBL9593237 0.74 DHFR (0.41) DHFRTDP1ALDH1A1GLATP53
SCHEMBL5857157 0.74 ALDH1A1 (0.43) DHFRTDP1ALDH1A1GLACYP1A2
SCHEMBL15380522 0.73 DHFR (0.79) DHFRALDH1A1CYP1A2CYP2C19TP53
SCHEMBL29558033 0.73 DHFR (0.79) DHFRALDH1A1CYP1A2CYP2C19TP53
SCHEMBL409180 0.73 DHFR (0.79) DHFRALDH1A1CYP1A2CYP2C19TP53
SCHEMBL15380515 0.73 DHFR (0.79) DHFRALDH1A1CYP1A2CYP2C19TP53
SCHEMBL30145441 0.73 DHFR (0.79) DHFRALDH1A1CYP1A2CYP2C19TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009115902-A1 PROCESS FOR THE PREPARATION OF CARVEDILOL VIA SILYL PROTECTION OF SUBSTITUTED AMINE CADILA PHARMACEUTICALS LTD. (IN) 2009-09-24 WO disclosed
EP-1833480-A2 CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST BETA-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE Artesian Therapeutics, Inc. (US) 2007-09-19 EP disclosed
WO-2006060122-A9 CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST BETA-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE ARTESIAN THERAPEUTICS INC (US) 2006-08-17 WO disclosed
WO-2006060122-A2 CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST BETA-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE ARTESIAN THERAPEUTICS, INC. (US) 2006-06-08 WO disclosed
WO-2004113296-A1 A PROCESS FOR PREPARATION OF 1-[9H-CARBAZOL-4-YLOXY]- 3-[{2-(2-(-(METHOXY)PHENOXY)-ETHYL}-AMINO]-PROPAN-2-OL SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2004-12-29 WO disclosed
WO-1998009625-A1 SELECTIVE β3 ADRENERGIC AGONISTS ELI LILLY AND COMPANY (US) 1998-03-12 WO disclosed